Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05263752 · ClinicalTrials.gov registry record
Evaluation of Safety and Efficacy of NvisionVLE® Imaging Low Profile System in Patients With Bile Duct Disease
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 3
- Enrollment target
NCT05263752: Completed study, sponsored by Methodist Health System.
NCT05263752 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05263752 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
A previous study evaluating the NvisionVLE® Imaging Low Profile System revealed the system to be feasible and safe for use in bile duct. The study also revealed a potential to better define abnormalities, target sampling and therapy when utilizing the NvisionVLE® Imaging Low Profile System. This study will further evaluate the safety and efficacy of the NvisionVLE® Imaging Low Profile System in patients with bile duct diseases.
Primary Outcome
Date of birth
Interventions
- DEVICE ERCP with NvisionVLE® Imaging Low Profile System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2017-10-18 |
| Est. Completion | 2020-06-30 |
What the finished NCT05263752 record still lists
NCT05263752 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which ERCP with NvisionVLE® Imaging Low Profile System is the first listed.
NCT05263752 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05263752 about?
NCT05263752 is a clinical study titled "Evaluation of Safety and Efficacy of NvisionVLE® Imaging Low Profile System in Patients With Bile Duct Disease". A previous study evaluating the NvisionVLE® Imaging Low Profile System revealed the system to be feasible and safe for use in bile duct. The study also revealed a potential to better define abnormalities, target sampling and therapy when utilizing the NvisionVLE® Imaging Low Profile System. This stu...
What is the current status of trial NCT05263752?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2017-10-18. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT05263752?
The interventions under investigation include: ERCP with NvisionVLE® Imaging Low Profile System (DEVICE).
Who is sponsoring clinical trial NCT05263752?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI